Cargando…
Acetylcholine Delays Atrial Activation to Facilitate Atrial Fibrillation
BACKGROUND: Acetylcholine (ACh) shortens action potential duration (APD) in human atria. APD shortening facilitates atrial fibrillation (AF) by reducing the wavelength for reentry. However, the influence of ACh on electrical conduction in human atria and its contribution to AF are unclear, particula...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6737394/ https://www.ncbi.nlm.nih.gov/pubmed/31551802 http://dx.doi.org/10.3389/fphys.2019.01105 |
_version_ | 1783450659351166976 |
---|---|
author | Bayer, Jason D. Boukens, Bastiaan J. Krul, Sébastien P. J. Roney, Caroline H. Driessen, Antoine H. G. Berger, Wouter R. van den Berg, Nicoline W. E. Verkerk, Arie O. Vigmond, Edward J. Coronel, Ruben de Groot, Joris R. |
author_facet | Bayer, Jason D. Boukens, Bastiaan J. Krul, Sébastien P. J. Roney, Caroline H. Driessen, Antoine H. G. Berger, Wouter R. van den Berg, Nicoline W. E. Verkerk, Arie O. Vigmond, Edward J. Coronel, Ruben de Groot, Joris R. |
author_sort | Bayer, Jason D. |
collection | PubMed |
description | BACKGROUND: Acetylcholine (ACh) shortens action potential duration (APD) in human atria. APD shortening facilitates atrial fibrillation (AF) by reducing the wavelength for reentry. However, the influence of ACh on electrical conduction in human atria and its contribution to AF are unclear, particularly when combined with impaired conduction from interstitial fibrosis. OBJECTIVE: To investigate the effect of ACh on human atrial conduction and its role in AF with computational, experimental, and clinical approaches. METHODS: S1S2 pacing (S1 = 600 ms and S2 = variable cycle lengths) was applied to the following human AF computer models: a left atrial appendage (LAA) myocyte to quantify the effects of ACh on APD, maximum upstroke velocity (V(max)), and resting membrane potential (RMP); a monolayer of LAA myocytes to quantify the effects of ACh on conduction; and 3) an intact left atrium (LA) to determine the effects of ACh on arrhythmogenicity. Heterogeneous ACh and interstitial fibrosis were applied to the monolayer and LA models. To corroborate the simulations, APD and RMP from isolated human atrial myocytes were recorded before and after 0.1 μM ACh. At the tissue level, LAAs from AF patients were optically mapped ex vivo using Di-4-ANEPPS. The difference in total activation time (AT) was determined between AT initially recorded with S1 pacing, and AT recorded during subsequent S1 pacing without (n = 6) or with (n = 7) 100 μM ACh. RESULTS: In LAA myocyte simulations, S1 pacing with 0.1 μM ACh shortened APD by 41 ms, hyperpolarized RMP by 7 mV, and increased V(max) by 27 mV/ms. In human atrial myocytes, 0.1 μM ACh shortened APD by 48 ms, hyperpolarized RMP by 3 mV, and increased V(max) by 6 mV/ms. In LAA monolayer simulations, S1 pacing with ACh hyperpolarized RMP to delay total AT by 32 ms without and 35 ms with fibrosis. This led to unidirectional conduction block and sustained reentry in fibrotic LA with heterogeneous ACh during S2 pacing. In AF patient LAAs, S1 pacing with ACh increased total AT from 39.3 ± 26 ms to 71.4 ± 31.2 ms (p = 0.036) compared to no change without ACh (56.7 ± 29.3 ms to 50.0 ± 21.9 ms, p = 0.140). CONCLUSION: In fibrotic atria with heterogeneous parasympathetic activation, ACh facilitates AF by shortening APD and slowing conduction to promote unidirectional conduction block and reentry. |
format | Online Article Text |
id | pubmed-6737394 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-67373942019-09-24 Acetylcholine Delays Atrial Activation to Facilitate Atrial Fibrillation Bayer, Jason D. Boukens, Bastiaan J. Krul, Sébastien P. J. Roney, Caroline H. Driessen, Antoine H. G. Berger, Wouter R. van den Berg, Nicoline W. E. Verkerk, Arie O. Vigmond, Edward J. Coronel, Ruben de Groot, Joris R. Front Physiol Physiology BACKGROUND: Acetylcholine (ACh) shortens action potential duration (APD) in human atria. APD shortening facilitates atrial fibrillation (AF) by reducing the wavelength for reentry. However, the influence of ACh on electrical conduction in human atria and its contribution to AF are unclear, particularly when combined with impaired conduction from interstitial fibrosis. OBJECTIVE: To investigate the effect of ACh on human atrial conduction and its role in AF with computational, experimental, and clinical approaches. METHODS: S1S2 pacing (S1 = 600 ms and S2 = variable cycle lengths) was applied to the following human AF computer models: a left atrial appendage (LAA) myocyte to quantify the effects of ACh on APD, maximum upstroke velocity (V(max)), and resting membrane potential (RMP); a monolayer of LAA myocytes to quantify the effects of ACh on conduction; and 3) an intact left atrium (LA) to determine the effects of ACh on arrhythmogenicity. Heterogeneous ACh and interstitial fibrosis were applied to the monolayer and LA models. To corroborate the simulations, APD and RMP from isolated human atrial myocytes were recorded before and after 0.1 μM ACh. At the tissue level, LAAs from AF patients were optically mapped ex vivo using Di-4-ANEPPS. The difference in total activation time (AT) was determined between AT initially recorded with S1 pacing, and AT recorded during subsequent S1 pacing without (n = 6) or with (n = 7) 100 μM ACh. RESULTS: In LAA myocyte simulations, S1 pacing with 0.1 μM ACh shortened APD by 41 ms, hyperpolarized RMP by 7 mV, and increased V(max) by 27 mV/ms. In human atrial myocytes, 0.1 μM ACh shortened APD by 48 ms, hyperpolarized RMP by 3 mV, and increased V(max) by 6 mV/ms. In LAA monolayer simulations, S1 pacing with ACh hyperpolarized RMP to delay total AT by 32 ms without and 35 ms with fibrosis. This led to unidirectional conduction block and sustained reentry in fibrotic LA with heterogeneous ACh during S2 pacing. In AF patient LAAs, S1 pacing with ACh increased total AT from 39.3 ± 26 ms to 71.4 ± 31.2 ms (p = 0.036) compared to no change without ACh (56.7 ± 29.3 ms to 50.0 ± 21.9 ms, p = 0.140). CONCLUSION: In fibrotic atria with heterogeneous parasympathetic activation, ACh facilitates AF by shortening APD and slowing conduction to promote unidirectional conduction block and reentry. Frontiers Media S.A. 2019-09-04 /pmc/articles/PMC6737394/ /pubmed/31551802 http://dx.doi.org/10.3389/fphys.2019.01105 Text en Copyright © 2019 Bayer, Boukens, Krul, Roney, Driessen, Berger, van den Berg, Verkerk, Vigmond, Coronel and de Groot. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Physiology Bayer, Jason D. Boukens, Bastiaan J. Krul, Sébastien P. J. Roney, Caroline H. Driessen, Antoine H. G. Berger, Wouter R. van den Berg, Nicoline W. E. Verkerk, Arie O. Vigmond, Edward J. Coronel, Ruben de Groot, Joris R. Acetylcholine Delays Atrial Activation to Facilitate Atrial Fibrillation |
title | Acetylcholine Delays Atrial Activation to Facilitate Atrial Fibrillation |
title_full | Acetylcholine Delays Atrial Activation to Facilitate Atrial Fibrillation |
title_fullStr | Acetylcholine Delays Atrial Activation to Facilitate Atrial Fibrillation |
title_full_unstemmed | Acetylcholine Delays Atrial Activation to Facilitate Atrial Fibrillation |
title_short | Acetylcholine Delays Atrial Activation to Facilitate Atrial Fibrillation |
title_sort | acetylcholine delays atrial activation to facilitate atrial fibrillation |
topic | Physiology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6737394/ https://www.ncbi.nlm.nih.gov/pubmed/31551802 http://dx.doi.org/10.3389/fphys.2019.01105 |
work_keys_str_mv | AT bayerjasond acetylcholinedelaysatrialactivationtofacilitateatrialfibrillation AT boukensbastiaanj acetylcholinedelaysatrialactivationtofacilitateatrialfibrillation AT krulsebastienpj acetylcholinedelaysatrialactivationtofacilitateatrialfibrillation AT roneycarolineh acetylcholinedelaysatrialactivationtofacilitateatrialfibrillation AT driessenantoinehg acetylcholinedelaysatrialactivationtofacilitateatrialfibrillation AT bergerwouterr acetylcholinedelaysatrialactivationtofacilitateatrialfibrillation AT vandenbergnicolinewe acetylcholinedelaysatrialactivationtofacilitateatrialfibrillation AT verkerkarieo acetylcholinedelaysatrialactivationtofacilitateatrialfibrillation AT vigmondedwardj acetylcholinedelaysatrialactivationtofacilitateatrialfibrillation AT coronelruben acetylcholinedelaysatrialactivationtofacilitateatrialfibrillation AT degrootjorisr acetylcholinedelaysatrialactivationtofacilitateatrialfibrillation |